- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: GMP.
Displaying page 1 of 2.
EudraCT Number: 2015-004497-15 | Sponsor Protocol Number: ERGO | Start Date*: 2016-12-12 | |||||||||||
Sponsor Name:UMBERTO I - POLICLINICO DI ROMA | |||||||||||||
Full Title: Study on New Insights in Remodeling of Endocrine Cardiomyopathies: Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A in C... | |||||||||||||
Medical condition: Cushing’s Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001191-68 | Sponsor Protocol Number: MSV-DISC-2008-01 | Start Date*: 2008-11-10 |
Sponsor Name:Institut de Terapia Regenerativa Tissular (ITRT) | ||
Full Title: “Regeneración del disco intervertebral lumbar mediante MSV*” *Células progenitoras de médula ósea autóloga, expandidas “Ex Vivo” con procedimiento GMP del Instituto de Biología y Genética Molecula... | ||
Medical condition: Pacientes con enfermedad degenerativa de uno o dos discos lumbares con predominio de dolor lumbar y/o citalagia persistente tras tratamiento conservador (médico y fisioteràpico) de mas de 6 meses ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004498-34 | Sponsor Protocol Number: SUM | Start Date*: 2016-12-12 | |||||||||||
Sponsor Name:UMBERTO I - POLICLINICO DI ROMA | |||||||||||||
Full Title: Study on New Insights in Remodeling of Endocrine Cardiomyopathies: ASsessmentt of Intramyocardial, Molecular and NeUroendocrine Parameters in Response to Chronic Inhibition of Cyclic GMP Phosphodie... | |||||||||||||
Medical condition: Acromegaly | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002109-24 | Sponsor Protocol Number: 09122019 | Start Date*: 2019-08-01 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum | ||
Medical condition: Pseudoxanthoma elasticum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001022-22 | Sponsor Protocol Number: COV-2-STs | Start Date*: 2021-05-14 |
Sponsor Name:Γενικό Νοσοκομείο Θεσσαλονίκης "Γεώργιος Παπανικολάου" | ||
Full Title: Generation of SARS-CoV-2-specific T lymphocytes from recovered donors and administration to high-risk COVID-19 patients | ||
Medical condition: COVID-19 high-risk patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000930-37 | Sponsor Protocol Number: STEMQUIRI/12ES01 | Start Date*: 2014-04-29 | |||||||||||
Sponsor Name:Laboratorios Salvat, S.A. | |||||||||||||
Full Title: A phase II clinical trial to assess the effect of HC-SVT-1001 (autologous fat stem adult mesenchymal cells expanded and combined with a tricalcium phosphate biomaterial) and HC-SVT-1002 (allogeneic... | |||||||||||||
Medical condition: Atrophic pseudarthrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016449-24 | Sponsor Protocol Number: XCEL-M-09-01 | Start Date*: 2010-06-15 |
Sponsor Name:Banc de Sang i Teixits (BST) | ||
Full Title: Regeneración del cartílago articular en gonartrosis de IIº y IIIer grados mediante infiltración articular de Xcel-m-condro-alfa* *Células progenitoras mesenquimales de médula ósea autóloga, expand... | ||
Medical condition: Gonartrosis grados II y III de Kellgren y Lawrence | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001221-24 | Sponsor Protocol Number: 01/2011tk | Start Date*: 2012-01-05 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Specific immunotherapy of birch pollen-related food allergy | ||
Medical condition: Allergy to apple in birch pollen allergic patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017405-11 | Sponsor Protocol Number: MSV-ARTRO-2009-01 | Start Date*: 2010-05-06 |
Sponsor Name:Fundación Teknon | ||
Full Title: Regeneración del cartílago articular en gonartrosis de IIº, IIIº y IVº grados mediante infiltración articular de MSV* *Células progenitoras de médula ósea autóloga, expandidas Ex Vivo con proced... | ||
Medical condition: Pacientes diagnosticados de gonartrosis grados IIº,IIIº,IVº de Kellgren y Lawrence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001720-19 | Sponsor Protocol Number: XRS-ITRT-2018 | Start Date*: 2018-12-12 | |||||||||||
Sponsor Name:Institut de Terapia Regenerativa Tissular S.L. (ITRT) | |||||||||||||
Full Title: Phase II clinical trial to evaluate the effect and safety of MSV * in Xerostomia * adult autologous bone marrow mesenchymal stem cells, expanded under GMP of IBGM | |||||||||||||
Medical condition: Xerostomia post radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000391-28 | Sponsor Protocol Number: 951404713 | Start Date*: 2017-09-20 | |||||||||||
Sponsor Name:INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON | |||||||||||||
Full Title: A PHASE II, DOUBLE-BLIND, CONTROLLED, PARALLEL-ARM TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INFUSION OF ALLOGENIC MESENCHYMAL STEM CELLS IN LUPUS NEPHRITIS (LN) | |||||||||||||
Medical condition: LUPUS NEPHRITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004441-32 | Sponsor Protocol Number: MSV-crio | Start Date*: 2013-03-06 | |||||||||||
Sponsor Name:Fundación Teknon | |||||||||||||
Full Title: Pilot clinical trial to determine the feasibility and safety of MSV * cryopreserved in the treatment of gonartrosis. * MSV = mesenchymal progenitor cells of expanded autologous bone marrow with GMP... | |||||||||||||
Medical condition: Patients diagnosed with gonarthrosis II, III and IV degrees of Kellgren and Lawrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004211-31 | Sponsor Protocol Number: CCR3894 | Start Date*: 2014-08-20 |
Sponsor Name:The Royal Marsden NHS Foundation Trust | ||
Full Title: Randomised double-blind controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline (PTX) in patients suffering long-term adverse effects of radiotherapy for pelvic cancer | ||
Medical condition: Adverse effects of radiotherapy for pelvic cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003691-40 | Sponsor Protocol Number: LUMC2010-01 | Start Date*: 2012-09-19 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Administration of leukemia-reactive donor T cells after allogeneic stem cell transplantation or donor lymphocyte infusion to patients with persistent or relapsed mature B cell neoplasm with blood a... | ||
Medical condition: persistent or relapsed mature B cell neoplasm with blood and/or bone marrow involvement | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024307-27 | Sponsor Protocol Number: LUMC2010-03 | Start Date*: 2011-11-01 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: TREATMENT WITH CMV PP65-SPECIFIC T CELLS GENERATED BY USE OF A CMV PP65 PROTEIN-SPANNING PEPTIDE POOL IN PATIENTS WITH CMV REACTIVATION OR CMV DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION | ||
Medical condition: CMV reactivation after allogeneic stem cell transplantation | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005929-49 | Sponsor Protocol Number: VX11-787-101 | Start Date*: 2012-02-20 | |||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Phase 2a, Randomized, Double Blind, Placebo Controlled Study to Investigate the Effects of VX 787 Administered to Adult Volunteers Experimentally Inoculated with Live Influenza Virus | |||||||||||||
Medical condition: Influenza A | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004938-42 | Sponsor Protocol Number: EHRVI | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Experimental Human Rhinovirus Infection, a randomized placebo-controlled pilot study | |||||||||||||
Medical condition: Viral infections in general, and the "common cold" induced by HRV-16 in particular. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000609-10 | Sponsor Protocol Number: 2020-01-GMF-1 | Start Date*: 2021-07-06 | |||||||||||
Sponsor Name:Center for Surgical Science | |||||||||||||
Full Title: A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch anal anastomosis surgery A clinical safety and proof-of-con... | |||||||||||||
Medical condition: A combination of GM-CSF and metronidazole/fosfomycin treatment for pouchitis in Ulcerative Colitis patients after ileal-pouch-anal anastomosis surgery given as an enema or spray in the pouch. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003876-29 | Sponsor Protocol Number: GMPO-131-002 | Start Date*: 2017-05-16 | |||||||||||
Sponsor Name:Orphalan | |||||||||||||
Full Title: CHELATE STUDY: Trientine tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s disease | |||||||||||||
Medical condition: Wilson's disease (WD) is a life-threatening inborn error of copper metabolism leading to an excessive copper accumulation, mainly in the liver or brain, causing hepatic and neurologic severe symptoms. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015600-26 | Sponsor Protocol Number: CSPP100ADE05T | Start Date*: 2009-12-07 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Würzburg | ||||||||||||||||||
Full Title: An open label prospective pilot-study to determine the improvement of impaired endothelial function and endothelial progenitor cell numbers following treatment with Aliskiren 300 mg in patients wit... | ||||||||||||||||||
Medical condition: Determination of the improvement of impaired endothelial function and endothelial progenitor cell numbers following treatment with Aliskiren 300 mg in patients with coronary artery disease and hype... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
